Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders

26 Oct 2023

Abstract excerpt

Neuropsychiatric disorders (NDs) are a diverse group of pathologies, including schizophrenia or bipolar disorders, that directly affect the mental and physical health of those who suffer from them, with an incidence that is increasing worldwide. Most NDs result from a complex interaction of multiple genes and environmental factors such as stress or traumatic events, including the recent Coronavirus Disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines, Inflammation, and Metabolic Diseases
Share to Hormonal Regulation and Hypertension
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37958618
DOI: 10.3390/ijms242115631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric DisordersPMID 37958618Read ↗

Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative DisordersSemantic proximity Read ↗

The role of apolipoproteins as genetic biomarkers in schizophrenia: A systematic review.Semantic proximity Read ↗

[Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].Semantic proximity Read ↗

Discovery and development of integrative biological markers for schizophrenia.Semantic proximity Read ↗

Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorderSemantic proximity Read ↗

Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Semantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

Association between lipid metabolism and cognitive function in patients with schizophreniaSemantic proximity Read ↗

Relevance of Diet in Schizophrenia: Focusing on Prenatal Nutritional Deficiency, Obesity, Oxidative Stress and InflammationSemantic proximity Read ↗

Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity Read ↗

The difference in serum proteomes in schizophrenia and bipolar disorderSemantic proximity Read ↗

Proteomics Research in SchizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.